CFO4Life Group’s iShares Core S&P 500 ETF IVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Sell
983
-133
-12% -$96.8K 0.1% 103
2026
Q1
$729K Buy
1,116
+114
+11% +$77.8K 0.11% 89
2025
Q4
$686K Sell
1,002
-736
-42% -$500K 0.1% 98
2025
Q3
$1.16M Hold
1,738
0.17% 66
2025
Q2
$1.08M Hold
1,738
0.17% 68
2025
Q1
$976K Buy
1,738
+44
+3% +$26K 0.16% 76
2024
Q4
$998K Sell
1,694
-13
-0.8% -$7.7K 0.18% 67
2024
Q3
$985K Buy
1,707
+744
+77% +$414K 0.17% 70
2024
Q2
$527K Buy
963
+102
+12% +$53.6K 0.1% 108
2024
Q1
$453K Buy
861
+261
+44% +$131K 0.08% 120
2023
Q4
$287K Buy
600
+23
+4% +$10.3K 0.05% 143
2023
Q3
$248K Sell
577
-71
-11% -$31.8K 0.06% 134
2023
Q2
$289K Buy
648
+72
+13% +$30.3K 0.06% 135
2023
Q1
$237K Buy
+576
New +$231K 0.05% 142
2017
Q3
Sell
-842
Closed -$205K 106
2017
Q2
$205K Sell
842
-1,794
-68% -$433K 0.19% 84
2017
Q1
$625K Buy
+2,636
New +$617K 0.57% 29

Other funds holding IVV

CFO4Life Group's IVV Position: Q2 2026 in Review

CFO4Life Group reduced its iShares Core S&P 500 ETF (IVV) stake by 12% in Q2 2026, selling an estimated $96.8K and leaving 983 shares worth $736K. The position accounts for 0.1% of the portfolio, ranked #103.

CFO4Life Group first reported a position in IVV in Q1 2017 and has held it in 16 quarters since. The position peaked at $1.16M in Q3 2025. 4,085 funds tracked by Wall St. Rank hold IVV as of Q2 2026.

  • CFO4Life Group held 983 shares of iShares Core S&P 500 ETF worth $736K as of Q2 2026.
  • CFO4Life Group sold 133 iShares Core S&P 500 ETF shares in Q2 2026, an estimated $96.8K.
  • iShares Core S&P 500 ETF made up 0.1% of CFO4Life Group's portfolio in Q2 2026, its #103 holding.
  • CFO4Life Group first reported a position in iShares Core S&P 500 ETF in Q1 2017 and has held it in 16 quarters since.
  • CFO4Life Group's iShares Core S&P 500 ETF position peaked at $1.16M in Q3 2025.
  • 4,085 funds tracked by Wall St. Rank held iShares Core S&P 500 ETF as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.